Genomic profiling of ER breast cancers after short-term estrogen suppression reveals alterations associated with endocrine resistance.

Giltnane JM, Hutchinson KE, Stricker TP, Formisano L, Young CD, Estrada MV, Nixon MJ, Du L, Sanchez V, Ericsson PG, Kuba MG, Sanders ME, Mu XJ, Van Allen EM, Wagle N, Mayer IA, Abramson V, G¤îmez H, Rizzo M, Toy W, Chandarlapaty S, Mayer EL, Christiansen J, Murphy D, Fitzgerald K, Wang K, Ross JS, Miller VA, Stephens PJ, Yelensky R, Garraway L, Shyr Y, Meszoely I, Balko JM, Arteaga CL
Sci Transl Med. 2017 9 (402)

PMID: 28794284 · PMCID: PMC5723145 · DOI:10.1126/scitranslmed.aai7993

MeSH Terms (11)

Breast Neoplasms Cell Line, Tumor Cyclin-Dependent Kinase 4 Cyclin-Dependent Kinase 6 Cyclin D1 Female Humans In Vitro Techniques Receptor, ErbB-2 Receptor, Fibroblast Growth Factor, Type 1 Receptors, Estrogen

Connections (2)

This publication is referenced by other Labnodes entities:

Links